Competition causing price deflation
Post# of 145248
![](/assets/46931549/no_avatar_available_thumb.jpg)
DoctorRx makes that point about the likely cabotegravir approval early next year and it's probably a good point. Nader needs to take into account competition when pricing leronlimab. Don't price Cytodyn out of the market.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)